Coding with receipts.
ANICA turns clinical records into evidence-backed ICD-10-CM, HCC and E/M decisions. DelPHI keeps protected health data inside the trust boundary.
A preview of healthcare after AGI
We are building the intelligence medicine can trust. Every decision evidenced, every patient private, every outcome proven.
Every intelligence so far has asked to be trusted. The next one will not need to. It will show the chart, the line, the evidence and the reasoning to anyone with the right to look. That is the only kind of superintelligence medicine should let in. It is the kind we are building.
A live run of the evidence engine on a synthetic note. Point at any finding to see exactly where it came from, and why one claim was refused.
72-year-old woman, scheduled follow-up.
Type 2 diabetes with diabetic kidney disease. A1c 8.1 today, continue metformin at reduced dose, recheck in 3 months.
CKD stage 3a, eGFR 52, stable. Avoid NSAIDs, nephrology referral placed.
Chronic systolic heart failure, EF 35% on last echo, euvolemic on exam, continue carvedilol and furosemide.
History of colon cancer, resected 2015, no evidence of recurrence on last colonoscopy.
Synthetic note. No real patient data.
The horizon
The first card is what we ship. The rest is where the same principle leads once intelligence passes ours.
ANICA turns clinical records into evidence-backed ICD-10-CM, HCC and E/M decisions. DelPHI keeps protected health data inside the trust boundary.
Agents carry each encounter from note to payment. Every step leaves evidence. People rule on the exceptions, not the routine.
Documentation forms during the visit, coded at the moment of care, with its evidence attached before the patient leaves the room.
Payer and provider reason over the same proof. Disagreement is settled before a claim is ever filed.
Every diagnosis, risk score and dollar in medicine traces back to evidence that anyone with the right to ask can inspect.
The agentic world is not humans replaced. It is every person surrounded by tireless help that reports back with evidence. Move your cursor: you are a human node too.
Autonomy dial
Draft
Agents, with evidence attached
Humans, with the final word
Turn the dial all the way and three tasks never move. Judgment, care and accountability stay human. Autonomy is earned one verified case at a time, and every agent action stays reviewable.
How a record moves
The trust boundary. It removes protected health information while keeping the clinical and coding context downstream intelligence needs. In public beta, managed on the web or fully offline on device.
A language model proposes. Deterministic rules verify. Every accepted diagnosis is tied to evidence that it was monitored, evaluated, assessed or treated.
In development. Revenue-cycle agents built on the same evidence and audit trail, so action never outruns proof.
Capability will keep compounding. These do not change. We hold our systems to them today.
No decision without the evidence that produced it, open to the people it affects.
Privacy is enforced at the boundary, before intelligence ever touches the record.
People keep the final word. Autonomy is earned one verified case at a time.
Performance is proven on adjudicated ground truth, never asserted in a headline.
Abundance
Exponential technologies follow six Ds, in Peter Diamandis's framing. Medicine is next in line.
Digitized
Every record, image and genome becomes data an intelligence can read.
Abundance in medicine needs one thing exponential technology does not supply on its own: trust at scale. That is the layer we build.
Up to 90%
automated.
100% reviewable.
1,000+
page clinical charts processed. Every accepted diagnosis tied to evidence in the source.
25-year
US-focused RCM organization, Anion, and its certified coders helped us build and refine it.
We benchmark on enterprise-grade evaluation sets with adjudicated ground truth and share full precision, recall and F1 under NDA. We do not publish headline accuracy numbers. Headline numbers are what fail audits.
















Health plans, revenue-cycle teams, builders and investors who want to shape it: we would like to hear from you.
Talk to us